Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK134612 Persistence and Booster Study in Toddlers
NCT00955682Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2009
- Primary completion
- Dec 2009
- Countries
- 1
01
Overview
A Phase 3 trial of meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine in meningococcal infection, sponsored by GSK. Started Aug 2009; status: completed.
02
Drugs
meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT00955682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00955682.